【摘要】：背景與目的已有的研究表明:在多種惡性腫瘤中發(fā)現(xiàn)轉(zhuǎn)移相關蛋白1(metastasis associated protein1,MTA1)發(fā)揮著促進腫瘤侵襲與轉(zhuǎn)移的作用,且與腫瘤患者預后不佳有關。目前MTA1在肺癌中的預后作用仍有爭議,故我們采用meta分析的方法評估其在肺癌患者中的預后價值。方法通過計算機檢索PubMed、Embase、萬方數(shù)據(jù)庫、中國生物醫(yī)學文獻數(shù)據(jù)庫、中國知網(wǎng)等數(shù)據(jù)庫,收集納入研究MTA1表達與肺癌預后關系的文獻及相關數(shù)據(jù),采用Stata 12.0軟件進行數(shù)據(jù)分析,合并值為風險比(hazard ratio,HR)。結(jié)果總共納入8項研究共712例中國肺癌患者,對這些研究進行異質(zhì)性檢驗,發(fā)現(xiàn)存在異質(zhì)性(I~2=59.0%,P=0.017),故采用隨機效應模型進行數(shù)據(jù)合并得HR=2.07(95%CI:1.42-3.02,P0.001)。同時分層分析顯示在非小細胞肺癌(non-small cell lung cancer,NSCLC)中各研究無明顯異質(zhì)性(I~2=47.0%,P=0.093),采用固定效應模型合并得HR=1.66(95%CI:1.27-2.18,P0.001)。結(jié)論 MTA1高表達可能是中國NSCLC患者預后不良的一個指標,在肺癌及小細胞肺癌中的預后價值尚缺乏證據(jù)。
[Abstract]:Background & AIM previous studies have shown that metastasis associated protein 1 (metastasis associated protein1,MTA1) plays a role in promoting tumor invasion and metastasis in various malignant tumors and is related to poor prognosis of tumor patients. At present, the prognostic role of MTA1 in lung cancer is still controversial, so we use the method of meta analysis to evaluate its prognostic value in patients with lung cancer. Methods PubMed,Embase, Wanfang database, Chinese biomedical literature database and China knowledge network database were searched by computer to collect the literature and related data about the relationship between the expression of MTA1 and the prognosis of lung cancer. Stata 12.0 software was used to analyze the data, and the combined value was risk ratio (hazard ratio,HR). Results A total of 712 patients with lung cancer in China were enrolled in 8 studies. The heterogeneity of these studies was tested and heterogeneity was found. Therefore, the random effect model is used to combine the data to obtain HR=2.07 (95 CI: 1.42-3.02 P0.001). At the same time, stratification analysis showed that there was no significant heterogeneity in all studies of non-small cell lung cancer (non-small cell lung cancer,NSCLC). The fixed effect model was used to combine HR=1.66 (95 CI: 1.27-2.18). P0.001) Conclusion the high expression of MTA1 may be an indicator of poor prognosis in patients with NSCLC in China, and the prognostic value in patients with lung cancer and small cell lung cancer is still lack of evidence.
【作者單位】： 南京醫(yī)科大學附屬南京醫(yī)院呼吸科;
【基金】：江蘇省臨床醫(yī)學科技專項(No.BE2015611)資助~~
【分類號】：R734.2

【相似文獻】

相關期刊論文 前5條

1 楊磊;腫瘤轉(zhuǎn)移相關基因mta1和腫瘤[J];醫(yī)學綜述;2003年01期

2 何妮;趙蔭農(nóng);;腫瘤轉(zhuǎn)移相關基因MTA1與腫瘤關系的研究進展[J];中國醫(yī)學文摘(腫瘤學);2005年03期

3 錢錦賢;李定彪;洪志鵬;;腫瘤轉(zhuǎn)移相關基因MTA1在腫瘤中的研究進展[J];云南醫(yī)藥;2008年05期

4 劉躍華;;低位直腸癌保肛手術中直腸沖洗治療對預后的影響[J];臨床醫(yī)學;2014年05期

5 楊雪飛;毛曉韻;范垂鋒;黃挺;;香煙提取物對人非小細胞肺癌細胞系侵襲力及MTA1表達的影響[J];腫瘤學雜志;2012年11期

相關博士學位論文 前1條

1 許小濤;腫瘤轉(zhuǎn)移相關基因MTA1與鼻咽癌惡性程度和轉(zhuǎn)移的相關分析[D];武漢大學;2012年

，

本文編號：2410504